Richard A Baron
First SEC filing: Aug. 2, 2012 · Latest: Aug. 2, 2012
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 8, 2023 | IMNM | A | 6,500 | · | · | 6,500 Direct | · | Acquired | (price as of 2026-10-06) |
| June 16, 2022 | IMNM | A | 6,500 | · | · | 6,500 Direct | · | Acquired | (price as of 2026-10-06) |
| Aug. 18, 2021 | IMNM | M | 2,343 | · | · | 5,157 Direct | -31.24% | Disposed | (price as of 2026-10-06) |
| Aug. 18, 2021 | IMNM | M | 2,343 | $11.38 | $26,663 | 2,343 Direct | · | Acquired | 80.5% (price as of 2026-10-06) |
| May 28, 2021 | IMNM | A | 3,750 | · | · | 3,750 Direct | · | Acquired | (price as of 2026-10-06) |
| Nov. 3, 2020 | IMNM | A | 7,500 | · | · | 7,500 Direct | · | Acquired | (price as of 2026-10-06) |
| May 2, 2014 | GMED | M | 30,000 | · | · | 62,307 Direct | -32.50% | Disposed | (price as of 2026-10-06) |
| May 2, 2014 | GMED | S | 30,000 | $24.52 | $735,600 | 0 Direct | -100.00% | Disposed | 210.1% (price as of 2026-10-06) |
| May 2, 2014 | GMED | M | 30,000 | $10.34 | $310,200 | 30,000 Direct | · | Acquired | 635.3% (price as of 2026-10-06) |
| Jan. 23, 2014 | GMED | A | 30,000 | · | · | 30,000 Direct | · | Acquired | (price as of 2026-10-06) |
| Jan. 24, 2013 | GMED | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-06) |
| Aug. 8, 2012 | GMED | J | 92,307 | · | · | 92,307 Direct | · | Acquired | (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 8, 2023 | IMNM | Stock Option (Right to Buy) | Common Stock | $4.84 | June 8, 2033 | 6,500 | Acquired |
| June 16, 2022 | IMNM | Stock Option (Right to Buy) | Common Stock | $2.62 | June 16, 2032 | 6,500 | Acquired |
| Aug. 18, 2021 | IMNM | Stock Option (Right to Buy) | Common Stock | $11.38 | Nov. 3, 2030 | 2,343 | Disposed |
| May 28, 2021 | IMNM | Stock Option (Right to Buy) | Common Stock | $20.92 | May 28, 2031 | 3,750 | Acquired |
| Nov. 3, 2020 | IMNM | Stock Option (Right to Buy) [F1] | Common Stock | $11.38 | Nov. 3, 2030 | 7,500 | Acquired |
| May 2, 2014 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $10.34 | Feb. 2, 2022 | 30,000 | Disposed |
| Jan. 23, 2014 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $23.95 | Jan. 23, 2024 | 30,000 | Acquired |
| Jan. 24, 2013 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $13.04 | Jan. 24, 2023 | 25,000 | Acquired |
| Aug. 8, 2012 | GMED | Stock Option (Right to Buy Class A Common Stock) [F1] | Class A Common Stock [F1] | $10.34 | Feb. 2, 2022 | 92,307 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 2, 2012 | GMED | Stock Option (Right to Buy Class C Common Stock) [F1] | · | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $329,600 | · | · | $303,052 | $175,598 | · | $30,763 | $839,013 |
| 2013 | $329,600 | · | · | · | $177,371 | · | $30,922 | $678,299 |
| 2012 | $320,000 | · | · | · | $268,925 | · | $32,095 | $1,176,020 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.